{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-020718","form_type":"8-K","ticker":"NSPR","cik":"0001433607","company_name":"InspireMD, Inc.","filed_at":"2025-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.397682+00:00","generated_at":"2026-05-17T00:35:52.242390+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"InspireMD Q3 revenue record $2.5M (+39% YoY) as U.S. CGuard Prime launch gains traction","bullets":["U.S. revenue of $497k marks first commercial quarter for CGuard Prime carotid stent system.","Net loss $12.7M ($0.17/share) vs $7.9M ($0.16) a year ago; operating expenses up 57% on U.S. expansion.","Cash and marketable securities $63.4M at Sep 30, up from $34.6M at Dec 31, 2024, boosted by $58M July offering.","Over 100 U.S. carotid procedures completed; appointed Peter A. Soukas, M.D. as CMO and Dan Dearen to board.","Gross profit nearly doubled to $864k on favorable shift toward higher-margin U.S. sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-020718","json":"https://secwatch.observer/filing/0001493152-25-020718.json","markdown":"https://secwatch.observer/filing/0001493152-25-020718.md","text":"https://secwatch.observer/filing/0001493152-25-020718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1433607/000149315225020718/0001493152-25-020718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1433607/000149315225020718/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:35:52.242390+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}